Synthesis and biological evaluation of fluoropyrazolesulfonylurea and thiourea derivatives as possible antidiabetic agents

References

• Fokin AV, Kolomiyets AF. Some new approaches to modifying aromatic and heteroaromatic compounds by means of fluorine-containing substituents. J Fluor Chem 1988;40:247–59
   Web of Science ®Google Scholar
• Yamazaki T, Taguchi T, Ojima I. Unique properties of fluorine and their relevance to medicinal chemistry and chemical biology. Fluorine in medicinal chemistry and chemical biology. Chichester, UK: John Wiley & Sons, Ltd; 2009:1–46
   Google Scholar
• Bickerton GR, Paolini GV, Besnard J, et al. Quantifying the chemical beauty of drugs. Nature Chem 2012;4:90–8
   PubMed Web of Science ®Google Scholar
• Smart BE. Fluorine substituent effects (on bioactivity). J Fluor Chem 2001;109:3–11
   Web of Science ®Google Scholar
• Ismail FMD. Important fluorinated drugs in experimental and clinical use. J Fluor Chem 2002;118:27–33
   Web of Science ®Google Scholar
• Wang DJ, Fan L, Zheng CY, et al. Synthesis and anti-microbial activity of some new fluorinated 1H-pyrazoles. J Fluor Chem 2010;131:584–6
   Web of Science ®Google Scholar
• Yonetoku Y, Kubota H, Okamoto Y, et al. Novel potent and selective calcium-release-activated calcium (CRAC) channel inhibitors. Part 2: Synthesis and inhibitory activity of aryl-3-trifluoromethylpyrazoles. Bioorg Med Chem 2006;14:5370–83
   PubMed Web of Science ®Google Scholar
• Cusan C, Spalluto G, Prato M, et al. Synthesis and biological evaluation of a new class of acyl derivatives of 3-amino-1-phenyl-4,5-dihydro-1H-pyrazol-5-one as potential dual cyclooxygenase (COX-1 and COX-2) and human lipoxygenase (5-LOX) inhibitors. Il Farmaco 2005;60:327–32
   PubMedGoogle Scholar
• Desiraju G, Gopalakrishnan B, Jetti R, et al. Three-dimensional quantitative structural activity relationship (3d-qsar) studies of some 1,5-diarylpyrazoles: analogue based design of selective cyclooxygenase-2 inhibitors. Molecules 2000;5:945–55
   Web of Science ®Google Scholar
• Reddy MVR, Billa VK, Pallela VR, et al. Design, synthesis, and biological evaluation of 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-indolyl pyrazolines as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) inhibitors. Bioorg Med Chem 2008;16:3907–16
   PubMed Web of Science ®Google Scholar
• Kees KL, Fitzgerald JJ, Steiner KE, et al. New potent antihyperglycemic agents in db/db mice:  synthesis and structure − activity relationship studies of (4-substituted benzyl)(trifluoromethyl)pyrazoles and -pyrazolones. J Med Chem 1996;39:3920–8
   PubMed Web of Science ®Google Scholar
• Gerritsen GC, Dulin WE. The effect of 5-methylpyrazole-3-carboxylic acid on carbohydrate and free fatty acid metabolism. J Pharm Exp Ther 1965;150:491–8
   PubMed Web of Science ®Google Scholar
• Gerritsen GC, Dulin WE. Effect of a new hypoglycemic agent, 3,5-dimethylpyrazole, on carbohydrate and free fatty acid metabolism. Diabetes 1965;14:507–15
   PubMed Web of Science ®Google Scholar
• Wright JB, Dulin WE, Markillie JH. The antidiabetic activity of 3,5-dimethylpyrazoles. J Med Chem 1964;7:102–5
   PubMed Web of Science ®Google Scholar
• Allah HMF, Mokhtar HM, Soliman R. Synthesis and spectra of new 3-carbethoxypyrazole sulfonylurea derivatives. J Heterocyclic Chem 1981;18:1561–4
   Web of Science ®Google Scholar
• Soliman R, Faid-Allah HM, El Sadany SK. Preparation and antidiabetic activity of new substituted 3,5-diarylpyrazolesulfonylurea derivatives II: Structure-activity relationship. J Pharm Sci 1987;76:626–32
   PubMed Web of Science ®Google Scholar
• Soliman R, Feid-Allah HM. Preparation and antidiabetic activity of new 3-methyl-5-phenylpyrazolesulfonylurea derivatives. J Pharm Sci 1981;70:602–5
   PubMed Web of Science ®Google Scholar
• Soliman R, Feid-Allah HM, Mohamed HF. Preparation and antidiabetic activity of cyclic sulfonylthiourea derivatives. J Pharm Sci 1981;70:952–6
   PubMed Web of Science ®Google Scholar
• Soliman R, Feid-Allah HM, Sadany SKE, et al. Preparation and antidiabetic activity of new substituted 3,5-diarylpyrazolesulfonylurea derivatives. J Pharm Sci 1981;70:606–10
   PubMed Web of Science ®Google Scholar
• Soliman R, Mokhtar H, El Ashry ES. The scope of the reactions of hydrazines and hydrazones. Part 4: trisubstituted pyrazoles of possible hypoglycemic and antibacterial activity. Die Pharmazie 1978;33:184–5
   PubMed Web of Science ®Google Scholar
• Al-Saadi MS, Faidallah HM, Rostom SA. Synthesis and biological evaluation of some 2,4,5-trisubstituted thiazole derivatives as potential antimicrobial and anticancer agents. Arch Pharm 2008;341:424–34
   PubMed Web of Science ®Google Scholar
• Faidallah H, Al-Saadi M, Rostom SF, et al. Synthesis of some sulfonamides, disubstituted sulfonylureas or thioureas and some structurally related variants. A class of promising antitumor agents. Med Chem Res 2007;16:300–18
   Web of Science ®Google Scholar
• Faidallah HM, Sharshira EM, Al-Saadi MSM. Synthesis and biological evaluation of some new alicyclicspiro-2′-(1′,3′-oxazolidine) derivatives. Heterocyclic Commun 2009;15:43–50
   Web of Science ®Google Scholar
• Asiri AM, Faidallah HM, Albar HM, et al. Synthesis of 1-p-sulfamylphenyl-3-trifluoromethylpyrazoles class of cyclooxygenase-2 inhibitors. Heterocyclic Commun 2003;9:483–8
   Web of Science ®Google Scholar
• Faidallah HM, Khan KA, Asiri AM. Synthesis and biological evaluation of new 3-trifluoromethylpyrazolesulfonyl-urea and thiourea derivatives as antidiabetic and antimicrobial agents. J Fluor Chem 2011;132:131–7
   Web of Science ®Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 1997;23:3–25
   Web of Science ®Google Scholar
• Veber DF, Johnson SR, Cheng HY, et al. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 2002;45:2615–23
   PubMed Web of Science ®Google Scholar
• Ertl P, Rohde B, Selzer P. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem 2000;43:3714–17
   PubMed Web of Science ®Google Scholar
• Sander T, Freyss J, von Korff M, et al. OSIRIS, an entirely in-house developed drug discovery informatics system. J Chem Inf Model 2009;49:232–46
   PubMed Web of Science ®Google Scholar
• Haslewood GAD, Strookman TA. A method for the estimation of “true” sugar in 0.05 ml of blood. Biochem J 1939;33:920–3
   PubMedGoogle Scholar
• Bhargava PN. The synthesis of some 3-aryl-2-arylimino-4-thiazolidones. J Amer Chem Soc 1951;73:2353–4
   Web of Science ®Google Scholar
• Eberly FA, Dains FB. On the formation and reactions of the substituted thiazolidones iv. J Am Chem Soc 1936;58:2544–7
   Google Scholar
• Jones ERH, Robinson FA, Strachan MN. 24. Some 5-spirothiazolidiones. J Chem Soc 1946;91–2. doi: 10.1039/JR9460000091
   PubMed Web of Science ®Google Scholar
• Bickerton GR, Paolini GV, Besnard J, et al. Quantifying the chemical beauty of drugs. Nat Chem 2012;4:90–8
   PubMed Web of Science ®Google Scholar
• Ali R, Siddiqui N. New benzo[d]thiazol-2-yl-aminoacetamides as potential anticonvulsants: synthesis, activity and prediction of molecular properties. Arch Pharm (Weinheim) 2015;348:254–65
   PubMed Web of Science ®Google Scholar
• Paramashivam SK, Elayaperumal K, Natarajan B, et al. In silico pharmacokinetic and molecular docking studies of small molecules derived from Indigofera aspalathoides Vahl targeting receptor tyrosine kinases. Bioinformation 2015;11:73–84
   PubMed Web of Science ®Google Scholar
• Zhao YH, Abraham MH, Le J, et al. Rate-limited steps of human oral absorption and qsar studies. Pharm Res 2002;19:1446–57
   PubMed Web of Science ®Google Scholar